Jaguar Health (JAGX) Net Equity Issued and Repurchased (2014 - 2025)

Jaguar Health (JAGX) has 10 years of Net Equity Issued and Repurchased data on file, last reported at $3.1 million in Q3 2025.

• On a quarterly basis, Net Equity Issued and Repurchased fell 88.85% year-over-year to $3.1 million in Q3 2025; TTM through Dec 2025 was $7.7 million, a 75.0% decrease from a year earlier, with the FY2025 full-year figure at $2.4 million, down 92.28% from the prior year.
• Net Equity Issued and Repurchased for Q3 2025 stood at $3.1 million, up from $1.5 million in the prior quarter.
• Over the last five years, Net Equity Issued and Repurchased for JAGX reached as high as $27.8 million in Q3 2024 and fell as low as -$11.6 million in Q3 2022.
• Historically, Net Equity Issued and Repurchased has averaged $3.7 million across 4 years, with a median of $3.0 million in 2024.
• Across the five-year window, Net Equity Issued and Repurchased jumped 347.39% in 2022 and sank 88.85% in 2025, its largest moves.
• Year by year, Net Equity Issued and Repurchased stood at $2.0 million in 2021, then plunged by 670.3% to -$11.6 million in 2022, then jumped by 125.86% to $3.0 million in 2024, then grew by 3.33% to $3.1 million in 2025.
• Per Business Quant data, the three most recent Net Equity Issued and Repurchased figures were $3.1 million in Q3 2025, $1.5 million in Q2 2025, and $3.1 million in Q1 2025.